Discovery of GST-HG171, A Potent and Selective Oral 3CL Protease Inhibitor for the Treatment of COVID-19
The coronavirus 3C-Like (3CL) protease, aka Main protease (Mpro), has become a clinically validated therapeutic target for developing new COVID-19 therapeutics with the recent success of Paxlovi... Download PDF
George Zhang*, John Mao, Haiying He, Ke Xu, Jing Zhou, Yaxun Yang, Yong Du, Hong Zhang, Peng Li, Shikui Chen, Yunlong Lin, Wenwen Lei, Hong Chen, Zheng Wang, Xiangyu Yang, Yanan Tang, Wenhao Yan, Zhengyu Liang, Juan Li, Shilong Zhu, Tianxiang Zhang, Chuanjing Li, Jiarong Lin, Xiuping Yan, Hongshan Tan, Hongming Li, Guoping Li, Haijun Fu, Wenfang Yuan, Xiaochun Chen, Zifeng Yang, Xinwen Chen, Yanhua Ding, Shuhui Chen*, Hongzhou Lu*, Guizhen Wu* and Nanshan Zhong